Effect of music therapy on anxiety and pain in the critical polytraumatised patient.

OBJECTIVE: To determine the effectiveness of music therapy on anxiety and pain in critical polytraumatised patients admitted to the resuscitation unit of a tertiary level hospital in Spain. MATERIAL AND METHOD: Randomised clinical trial conducted in a tertiary level hospital, from June 2016 to May 2018. The study sample was 60 patients, 30 belonging to the intervention group (IG), and 30 to the control group (CG). The IG were given a 30-minute music session and heart rate (HR) and blood pressure (BP) were measured. The VAS (Visual Analogue Scale) was applied for anxiety and pain before and after each session. The same measures and scales were applied in the CG who did not receive a music session. The music session comprised 3 parts: the first was standard music selected by music therapists; the second was personalised, chosen by the patient and the third was a new standard. The intervention took place in a booth with headphones. RESULTS: Significant changes in anxiety levels (P<.01) were detected in the group of patients undergoing the intervention, measured with the VAS scale for anxiety, and pain levels (P<.01), measured with the VAS scale for pain. No significant differences were found in the physiological parameters of HR and BP. CONCLUSION: The use of music in critical polytraumatised patients reduces anxiety and pain levels, increasing the patient's well-being and improving the quality of care. Music therapy, therefore, is considered beneficial as a complementary measure in critical care units. It would be worthwhile to continue studies in this and other hospital areas.

Effect of music therapy on anxiety and pain in the critical polytraumatised patient. / Efecto de la musicoterapia sobre la ansiedad y el dolor en el paciente crítico politraumatizado.

OBJECTIVE: To determine the effectiveness of music therapy on anxiety and pain in critical polytraumatised patients admitted to the resuscitation unit of a tertiary level hospital in Spain. MATERIAL AND METHOD: Randomised clinical trial conducted in a tertiary level hospital, from June 2016 to May 2018. The study sample was 60 patients, 30 belonging to the intervention group (IG), and 30 to the control group (CG). The IG were given a 30-minute music session and heart rate (HR) and blood pressure (BP) were measured. The VAS (Visual Analogue Scale) was applied for anxiety and pain before and after each session. The same measures and scales were applied in the CG who did not receive a music session. The music session comprised 3 parts: the first was standard music selected by music therapists; the second was personalised, chosen by the patient and the third was a new standard. The intervention took place in a booth with headphones. RESULTS: Significant changes in anxiety levels (P<.01) were detected in the group of patients undergoing the intervention, measured with the VAS scale for anxiety, and pain levels (P<.01), measured with the VAS scale for pain. No significant differences were found in the physiological parameters of HR and BP. CONCLUSION: The use of music in critical polytraumatised patients reduces anxiety and pain levels, increasing the patient's well-being and improving the quality of care. Music therapy, therefore, is considered beneficial as a complementary measure in critical care units. It would be worthwhile to continue studies in this and other hospital areas.

Interactive effect of dietary protein and dried citrus pulp levels on growth performance, small intestinal morphology, and hindgut fermentation of weanling pigs.

Weanling pigs ( = 108, 21 d of age, 5.82 ± 0.16 kg initial BW) were assigned to a 2 × 2 factorial arrangement of treatments to evaluate the effects of dietary levels of CP (high- and low-CP diets) and dried citrus pulp (DCP; 0% and 7.5%) on growth performance, small intestinal morphology, and hindgut fermentation. Pigs were blocked by initial BW and allotted to 1 of 9 pens, each containing 3 pigs. The high-CP diets consisted of feeding 20% and 21% CP levels throughout phase 1 (0 to 14 d) and phase 2 (14 to 28 d), respectively. For the low-CP diets, CP levels were reduced by 4% units as compared with the high-CP diets in both phases. Crystalline AA were supplied to maintain an ideal AA pattern. Pig BW and pen feed disappearance were recorded weekly. On d 7 and 28 postweaning, 1 pig from each pen was euthanized for collection of small intestinal tissues and digesta from cecum and colon. There were no CP × DCP interactions for growth performance and gut morphology. Although the low-CP diet decreased ADG ( = 0.03) and G:F ( = 0.02) from d 21 to 28 postweaning, overall performance was unaffected by the treatments. On d 7 postweaning, pigs fed the low-CP diet tended to have increased ( = 0.09) crypt depth in the duodenum. Low-CP diets tended to increase ( = 0.06) crypt depth and reduce ( = 0.08) villus:crypt ratio in the jejunum on d 7. Dietary treatments did not affect ileal morphology. On d 7 postweaning, low-CP diets tended to reduce ( = 0.09) cecal total VFA, whereas dietary DCP inclusion tended to decrease ( = 0.07) colonic propionate. Including 7.5% DCP to the diet decreased ( < 0.05) colonic isovalerate and ammonia N concentrations on d 7 only for pigs fed the low-CP diet. On d 28 postweaning, DCP inclusion in low-CP diets decreased ( < 0.05) butyrate, isovalerate, and valerate concentrations in the cecum, as well as isovalerate, valerate, and ammonia N concentrations in the colon. Including 7.5% DCP to the diet increased ( < 0.05) acetate:propionate ratio in the hindgut on both d 7 and 28 postweaning only for pigs fed the high-CP diet. Lactate concentration was unaffected by the treatments. These results indicate that feeding low-CP AA-supplemented diets did not compromise overall growth performance, but slightly increased damage in the gut morphology of weanling pigs. Moreover, adding 7.5% DCP to low-CP AA-supplemented diets shifted the fermentation pattern in the hindgut of weanling pigs by decreasing protein fermentation metabolites.

[Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice]. / Adaptación española de las guías europeas de 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica.

The VI European Guidelines for Cardiovascular Prevention recommend combining population and high-risk strategies with lifestyle changes as a cornerstone of prevention, and propose the SCORE function to quantify cardiovascular risk. The guidelines highlight disease specific interventions, and conditions as women, young people and ethnic minorities. Screening for subclinical atherosclerosis with noninvasive imaging techniques is not recommended. The guidelines distinguish four risk levels (very high, high, moderate and low) with therapeutic objectives for lipid control according to risk. Diabetes mellitus confers a high risk, except for subjects with type 2 diabetes with less than <10 years of evolution, without other risk factors or complications, or type 1 diabetes of short evolution without complications. The decision to start pharmacological treatment of arterial hypertension will depend on the blood pressure level and the cardiovascular risk, taking into account the lesion of target organs. The guidelines don't recommend antiplatelet drugs in primary prevention because of the increased bleeding risk. The low adherence to the medication requires simplified therapeutic regimes and to identify and combat its causes. The guidelines highlight the responsibility of health professionals to take an active role in advocating evidence-based interventions at the population level, and propose effective interventions, at individual and population level, to promote a healthy diet, the practice of physical activity, the cessation of smoking and the protection against alcohol abuse.

Atrofia muscular espinal y fracaso respiratorio. ¿Cómo actúan los pediatras de atención primaria en un escenario simulado? / Spinal muscular atrophy and respiratory failure. How do primary care pediatricians act in a simulated scenario?

Introducción: La atrofia muscular espinal tipo 1 (AME-1) suele ser mortal en el primer año de vida sin soporte ventilatorio. La decisión de iniciar dicho soporte o no supone un conflicto ético para los profesionales sanitarios. Material y métodos: Se incluyó un escenario de fracaso respiratorio agudo en un lactante con AME-1 en un programa de formación mediante simulación avanzada para pediatras de atención primaria (PAP). Se analizaron de forma sistemática las actuaciones de 34 grupos de 4 pediatras que participaron en 17 cursos. Se valoraron los aspectos clínicos, éticos y de comunicación con los padres. Resultados: La asistencia técnica inicial (administración de oxígeno y soporte ventilatorio inmediato) fue realizada correctamente por el 94% de los equipos. Sin embargo, los PAP tuvieron problemas al abordar los aspectos éticos del caso. Del 85% de los equipos que plantearon el conflicto ético a los padres, lo hizo por iniciativa propia el 29%, el 23% los excluyó de forma activa y solo el 6% los implicaron y tuvieron en cuenta su opinión en la toma de decisiones. Solo el 11,7% preguntó por la calidad de vida del niño y el 12% por su conocimiento del pronóstico de la enfermedad. Ninguno les explicó las alternativas de tratamiento ni trató de contactar con el pediatra de referencia. Conclusiones: Ante un caso simulado de AME-1, los PAP tienen dificultades para interactuar con la familia e implicarla en la toma de decisiones. La formación práctica de todos los pediatras debería incluir problemas de ética clínica (AU)

Introduction: Spinal muscular atrophy type 1 (SMA-1) tends to be fatal in the first year of life if there is no ventilatory support. The decision whether to start such support is an ethical conflict for healthcare professionals. Material and methods: A scenario of acute respiratory failure in an infant with SMA-1 has been included in a training program using advanced simulation for Primary Care pediatricians (PCP). The performances of 34 groups of 4 pediatricians, who participated in 17 courses, were systematically analyzed. Clinical, ethical and communication aspects with parents were evaluated. Results: The initial technical assistance (Administration of oxygen and immediate ventilatory support) was correctly performed by 94% of the teams. However, the PCP had problems in dealing with the ethical aspects of the case. Of the 85% of the teams that raised the ethical conflict with parents, 29% did so on their own initiative, 23% actively excluded them, and only 6% involved them and took their opinion into account in making decisions. Only 11.7% asked about the quality of life of children and 12% for their knowledge of the prognosis of the disease. None explained treatment alternatives, nor tried to contact the pediatrician responsible for the child. Conclusions: When faced with a simulated SMA-1 infant with respiratory failure, PCP have difficulties in interacting with the family, and to involve it in the decision making process. Practical training of all pediatricians should include case scenarios with an ethical clinical problema (AU)

Effect of calcium oxide inclusion in beef feedlot diets containing 60% dried distillers grains with solubles on ruminal fermentation, diet digestibility, performance, and carcass characteristics.

Two experiments were conducted to determine the effect of increasing dietary CaO on ruminal fermentation, diet digestibility, performance, and carcass characteristics of feedlot steers fed 60% dried distillers grains with solubles ( DDGS: ). In Exp. 1, 120 steers were allotted by weight (355 ± 7.9 kg) to 1 of 4 treatments containing 60% DDGS, 20% corn silage, 13.5 to 14.4% ground corn, 4% supplement, and 0 to 2.5% limestone on DM basis to determine the effects of CaO on performance and carcass characteristics. Treatments consisted of 0, 0.8, 1.6, or 2.4% CaO inclusion in the diet (DM basis), with CaO replacing limestone. Steers were slaughtered at a target BW of approximately 641 kg. In Exp. 2, 4 steers (initial BW = 288 ± 3 kg) were randomly allotted to the same diets in a 4 × 4 Latin square design (14-d periods) to determine the effects of CaO on ruminal pH, VFA, and nutrient digestibility. Statistical analyses were conducted using the MIXED procedure of SAS. Inclusion of CaO at 0.8, 1.6, and 2.4% increased ADG by 5.0, 3.9, and 0%, respectively, compared to 0% CaO (quadratic; P = 0.03). Intake was linearly decreased (P = 0.04) and G:F was linearly increased (P = 0.02) by CaO inclusion. Dressing percentage increased as CaO increased from 0 to 1.6% and then decreased for 2.4% CaO (quadratic; P < 0.01). In Exp. 2, steers fed 0% CaO had the greatest prefeeding ruminal pH, steers fed 0 and 0.8% CaO exhibited the most rapid postfeeding decline in ruminal pH, and steers fed 2.4% CaO exhibited a relatively stable ruminal pH throughout the 24-h period (treatment × time; P ≤ 0.01). Acetate, butyrate, and total VFA concentrations increased linearly (P ≤ 0.05) at 0, 3, 6, and 12 h postfeeding with increasing CaO. Propionate at 3 h postfeeding increased from 0 to 1.6% CaO and decreased from 1.6 to 2.4% CaO (quadratic; P = 0.10). Urine pH increased linearly (P ≤ 0.01) while urine output and urine ammonia decreased linearly (P ≤ 0.05) as CaO inclusion increased. Apparent NDF digestibility tended to increase (P = 0.07) and ADF digestibility did (P = 0.01) increase linearly with increasing concentrations of CaO. In conclusion, CaO improved ruminal pH variation, increased fiber digestibility, and decreased metabolic acid load in cattle fed 60% DDGS-based diets. Inclusion of CaO up to 1.6% was effective in improving performance of feedlot cattle.

Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment.

OBJECTIVE: To update the Spanish Society of Neurology's guidelines for subarachnoid haemorrhage diagnosis and treatment. MATERIAL AND METHODS: A review and analysis of the existing literature. Recommendations are given based on the level of evidence for each study reviewed. RESULTS: The most common cause of spontaneous subarachnoid haemorrhage (SAH) is cerebral aneurysm rupture. Its estimated incidence in Spain is 9/100 000 inhabitants/year with a relative frequency of approximately 5% of all strokes. Hypertension and smoking are the main risk factors. Stroke patients require treatment in a specialised centre. Admission to a stroke unit should be considered for SAH patients whose initial clinical condition is good (Grades I or II on the Hunt and Hess scale). We recommend early exclusion of aneurysms from the circulation. The diagnostic study of choice for SAH is brain CT (computed tomography) without contrast. If the test is negative and SAH is still suspected, a lumbar puncture should then be performed. The diagnostic tests recommended in order to determine the source of the haemorrhage are MRI (magnetic resonance imaging) and angiography. Doppler ultrasonography studies are very useful for diagnosing and monitoring vasospasm. Nimodipine is recommended for preventing delayed cerebral ischaemia. Blood pressure treatment and neurovascular intervention may be considered in treating refractory vasospasm. CONCLUSIONS: SAH is a severe and complex disease which must be managed in specialised centres by professionals with ample experience in relevant diagnostic and therapeutic processes.

Tratamiento inicial de la enfermedad de Parkinson clínicamente establecida / Initial treatment of clinically established Parkinson's disease

Introducción. La enfermedad de Parkinson es una enfermedad cuyo diagnóstico continúa siendo clínico y aunque en la actualidad no existe una solución definitiva para la misma, se dispone de diversos fármacos para su tratamiento. Desarrollo. Se repasan los distintos fármacos que pueden tener su utilidad en la fase inicial de la enfermedad: L-dopa, inhibidores de la catecol-o-metil-transferasa, agonistas dopaminérgicos, inhibidores de la monoamino-oxidasa tipo B, amantadina, zonisamida y anticolinérgicos; así como terapias no farmacológicas. Asimismo se dan unas pautas sobre cómo emplear estos fármacos de una forma racional. Conclusiones. Actualmente sólo rasagilina ha cumplido los requisitos para poder ser considerada como tratamiento modificador de la enfermedad. L-dopa sigue siendo el mejor tratamiento sintomático, pero su utilización se asocia a aparición de complicaciones motoras. Los agonistas dopaminérgicos o los inhibidores de la monoamino-oxidasa tipo B pueden ser alternativas para retrasar el uso de la L-dopa. Zonisamida puede ser útil de inicio en pacientes jóvenes con cuadros de predominio tremórico. Los anticolinérgicos pueden ser empleados de forma excepcional para control de temblor parkinsoniano intenso no controlable con otros fármacos en pacientes jóvenes. El ejercicio físico, la hidroterapia y la terapia de la voz también pueden aportar beneficios (AU)

ntroduction. The diagnosis of Parkinson's disease continues to be clinically-based and although there is currently no definitive solution for it, a number of drugs are available to treat it. Development. Here we review the different drugs that can be useful in the early phases of the disease. These include: L-dopa, catechol-O-methyl transferase inhibitors, dopamine agonists, monoamine oxidase type B inhibitors, amantadine, zonisamide and anticholinergic agents, as well as non-pharmacological therapies. Likewise, guidelines are also provided on how to use these drugs in a rational way. Conclusions. At present, only rasagiline complies with the requirements to be considered a disease-modifying treatment. L-dopa continues to be the best symptomatic treatment, but its use is associated with the appearance of motor complications. Dopamine agonists or monoamine oxidase type B inhibitors can be employed as alternatives to delay the use of L-dopa. Zonisamide can be useful in the early phases in young patients with clinical pictures in which tremor predominates. The anticholinergics can be employed exceptionally to control intense parkinsonian tremor in young patients that cannot be controlled with other drugs. Physical exercise, hydrotherapy and voice therapy can also be beneficial (AU)

PP134. l-Arginine supplementation induces the expression of genes related to antioxidant defense in cultures of human vascular endothelial cells: Protective role for preeclampsia.

INTRODUCTION: Recently, it has been proposed that supplementation with l-Arginine reduces the incidence of preeclampsia in high risk women, but the molecular mechanisms involved in the protective effect need to be determined. In addition, a critical role of l-Arginine in endothelial cell survival during oxidative stress, and the participation of neutrophils in the induction of oxidative stress during preeclampsia have been suggested. OBJECTIVES: To address if supplementation with l-arginine provides antioxidant defense in human vascular endothelial cells. METHODS: Human vascular endothelial cells (HUVECs) were isolated from umbilical cord veins obtained from healthy women underwent cesarean sections at term, with no evidence of hypertension disorders through the pregnancy. HUVECs were cultured in EndoGro media with LS supplement kit and 1% antibiotic with (n=10) or without 200uM l-Arginine (n=10). Confluent HUVECs were stimulated with neutrophils activated with 50umol/L arachidonic acid (1:16 ratio of neutrophil/cells). After incubation, cells were rinsed in PBS and harvested for RNA and protein extraction. Reverse transcription was performed using the RT(2) First Strand kit, and expression gene profiling was generated using the RT(2) Profiler PCR Array Human Oxidative Stress and Antioxidant Defense that includes the expression profile of 84 genes related to the oxidative pathway. Expression results were analyzed with the RT(2) Profiler PCR Array Data Analysis Template v3.0 and two different lists of fold change in gene expression were generated: (1) HUVEC+neutrophils vs HUVEC+l-Arginine + neutrophils and (2) HUVEC vs HUVEC+neutrophils. Validation of the expression assays was performed using western blots or ELISAS for proteins expressed by selected genes. RESULTS: Fold up- or down gene regulation are shown in Table 1. Forty six genes involved in oxidative stress defense were significantly up-regulated in HUVECs supplemented with l-arginine when were exposed to neutrophils. Interestingly, almost the same genes were down-regulated in non-supplemented HUVECs after neutrophil exposure. CONCLUSION: Supplementation with l-Arginine upregulates the expression of genes related to antioxidant defense in primary cultures of endothelial cells. This finding provides a novel insight about the molecular mechanisms involved in the protective role of l-Arginine during preeclampsia.

Morphological changes and virus distribution in the ileum of colostrum-deprived calves inoculated with non-cytopathic bovine viral diarrhoea virus genotype-1.

Eight colostrum-deprived calves were inoculated intranasally with a non-cytopathic strain of bovine viral diarrhoea virus (BVDV) genotype-1 and killed in batches of two at 3, 6, 9 and 14 days post-inoculation (dpi). Two non-inoculated animals with similar background served as controls. All infected calves developed mild pyrexia and transient leucopenia due primarily to lymphopenia. Viraemia was correlated with body temperature and inversely related to leucocyte count. Ileal Peyer's patches developed mild follicular lymphoid depletion from 3dpi. This change was accompanied by cellular fragmentation and pyknosis, characteristic of apoptosis, which was most prominent from 6dpi. Lymphocyte apoptosis was confirmed by ultrastructural examination. Stellate cells and macrophages located in the lymphoid follicles were identified as infected by virus from 3dpi and the number of these infected cells increased until 9dpi. Fewer lymphocytes expressed BVDV antigen. Macrophages had morphological features consistent with activation of secretory and phagocytic function from 3dpi. These findings suggest that BVDV is only directly responsible for the destruction of a small number of lymphocytes. Although lymphocyte infection coincided with the onset of apoptosis, the intensity of infection was disproportionate to the marked depletion of gut-associated lymphoid tissue, particularly during the early stages of this process. Characterization of the indirect pathogenic mechanisms involved in the lymphoid depletion associated with BVDV infection will require additional study.

Evaluation of the genotoxic potential of Mangifera indica L. extract (Vimang), a new natural product with antioxidant activity.

Mangifera indica L. extract (Vimang) consists of a defined mixture of components (polyphenols, terpenoids, steroids, fatty acids and microelements). It contains a variety of polyphenols, phenolic esters, flavan-3-ols and a xanthone (mangiferin), as main component. This extract has antioxidant action, antitumor and immunemodulatory effects proved in experimental models in both in vitro and in vivo assays. The present study was performed to investigate the genotoxicity potential activity of Vimang assessed through different tests: Ames, Comet and micronucleus assays. Positive and negative controls were included in each experimental series. Histidine requiring mutants of Salmonella typhimurium TA1535, TA1537, TA1538, TA98, TA100 and TA102 strains for point-mutation tests and in vitro micronucleus assay in primary human lymphocytes with and without metabolic activation were performed. In addition, genotoxic effects were evaluated on blood peripheral lymphocytes of NMRI mice of both sexes, which were treated during 2 days with intraperitoneal doses of M. indica L. extract (50-150 mg/kg). The observed results permitted to affirm that Vimang (200-5,000 microg/plate) did not increase the frequency of reverse mutations in the Ames test in presence or not of metabolic activation. Results of Comet assay showed that the extract did not induce single strand breaks or alkali-labile sites on blood peripheral lymphocytes of treated animals compared with controls. On the other hand, the results of the micronucleus studies (in vitro and in vivo) showed Vimang induces cytotoxic activity, determined as cell viability or PCE/NCE ratio, but neither increased the frequency of micronucleated binucleate cells in culture of human lymphocytes nor in mice bone marrow cells under our experimental conditions. The positive control chemicals included in each experiment induced the expected changes. The present results indicate that M. indica L. extract showed evidences of light cytotoxic activity but did not induce a mutagenic or genotoxic effects in the battery of assays used.

Retention of phosphorus by iron and aluminum-oxides-coated quartz particles.

The capacity of adsorption of P on Fe and Al-oxides-coated quartz sand has been studied. The adsorption process has been described as Freundlich and Langmuir isotherms. In all cases Langmuir equation yields better fits than Freundlich equation. The covering quartz particles with Fe and Al oxides provide a high capacity adsorption and immobilization of P from natural and waste waters. The values obtained for adsorption, desorption and adsorption/desorption cycles show that Al oxides particles provide an excellent material for construction of a P removal system for waste waters. The characteristics of this material would allow the design of a complementary filtration system to reduce P levels in the effluent, reducing contamination risks and combating eutrophication of nearby watercourses.

[Neurochemical treatment of Parkinson's disease and essential tremor]. / Tratamiento neuroquirúrgico en la enfermedad de Parkinson y el temblor esencial.

INTRODUCTION: Recent technological advances along with new neuroimaging techniques and progress in neuro-monitoring have provided us with new therapeutical options from the neurosurgical point of view in the management of movement disorders. Deep brain stimulators become more and more frequently used in the last few years since they have reversible effects, are easily implantable and have shown good initial results. However, only now we start knowing the clinical effects in the middle run. AIM: To review the main neurosurgical options in Parkinson's disease and tremor. DEVELOPMENT: We reviewed the articles considering ablative or stimulating neurosurgical treatments in these diseases, and we grouped the results according to the technique performed and the time of follow-up. CONCLUSION: Clinical results are often similar despite the use of different techniques. However, the side-effects are critical in deciding which technique should be used once medical therapy has been considered insufficient.

Differences in the suprachiasmatic nucleus and lower subparaventricular zone of diurnal and nocturnal rodents.

Diurnal and nocturnal species are profoundly different in terms of the temporal organization of daily rhythms in physiology and behavior. The neural bases for these divergent patterns are at present unknown. Here we examine functional differences in the suprachiasmatic nucleus (SCN) and one of its primary targets in a diurnal rodent, the unstriped Nile grass rat (Arvicanthis niloticus) and in a nocturnal one, the laboratory rat (Rattus norvegicus). Grass rats and laboratory rats were housed in a 12:12 light:dark cycle, and killed at six time points. cFos-immunoreactive rhythms in the SCN of grass rats and laboratory rats were similar to those reported previously, with peaks early in the light phase and troughs in the dark phase. However, cFos-immunoreactivity in the lower subparaventricular zone (LSPV) of grass rats rose sharply 5 h into the dark phase, and remained high through the first hour after light onset, whereas in laboratory rats it peaked 1 h after light onset and was low at all other sampling times. Daily cFos rhythms in both the SCN and the LSPV persisted in grass rats, but not in laboratory rats, after extended periods in constant darkness. In grass rats, the endogenous cFos rhythm in the LSPV, but not the SCN, was present both in calbindin-positive and in calbindin-negative cells. Cells that expressed cFos at night in the region of the LSPV in grass rats were clearly outside of the boundaries of the SCN as delineated by Nissl stain and immunoreactivity for vasopressin and vasoactive intestinal peptide. The LSPV of the grass rat, a region that receives substantial input from the SCN, displays a daily rhythm in cFos expression that differs from that of laboratory rats with respect to its rising phase, the duration of the peak and its dependence on a light/dark cycle. These characteristics may reflect the existence of mechanisms in the LSPV that enable it to modulate efferent SCN signals differently in diurnal and nocturnal species.

Effects of neonatal polychlorinated biphenyl exposure on female sexual behavior.

The effects of polychlorinated biphenyls (PCBs) on development and reproduction are well documented. However, very little is known about the effects of PCBs on sexual behavior. In this study, we examined the effects of two commercial PCB mixtures, Aroclor 1221 (A1221) and Aroclor 1254 (A1254), on the development of female sexual behavior and of the incertohypothalamic dopaminergic cells (A11 and A13) in Long-Evans rats. Neonatal exposure to A1254 significantly reduced sexual receptivity and reduced the female's latency to approach a male after an intromission. Neonatal treatment with A1221 did not affect female sexual behavior nor did treatment of adult females with A1221 or A1254. Since sexual behavior is affected by dopamine and since PCBs have been reported to alter dopamine content in the brain, we examined the effects of A1221 or A1254 on dopaminergic cells in the incertohypothalamic region of neonatally exposed rats. None of the treatments significantly affected the number of A11 or A13 neurons that were immunoreactive for tyrosine hydroxylase (TH) or the expression of Fos (i.e., the product of the immediate early gene c-fos) in these dopaminergic neurons. Therefore, the disruption of behavior induced by neonatal treatment with A1254 does not appear to be mediated by toxic effects of the mixture on incertohypothalamic dopaminergic systems.

Diferuloylputrescine and p-coumaroyl-feruloylputrescine, abundant polyamine conjugates in lipid extracts of maize kernels.

Extraction of corn bran or corn fiber with polar solvents such as methylene chloride, ethanol or chloroform/methanol yielded common lipids and two unknown high-performance liquid chromatography (HPLC) peaks, each with an ultraviolet absorbance maximum at 320 nm. HPLC-mass spectrometry revealed that the unknowns were diferuloylputrescine (DFP) and p-coumaroyl-feruloylputrescine (CFP). When compared to extracts of corn fiber (a pericarp-enriched fraction from the wet milling of corn), comparable extracts of corn bran (a pericarp- enriched fraction from the dry milling of corn) yielded three- to eightfold higher levels of DFP and CFP. Extraction of corn bran or fiber with an accelerated solvent extractor revealed that elevated temperatures greatly enhanced the extraction of DFP and CFP by methylene chloride and ethanol. "Corn bran oil," prepared by extraction of corn bran with hot methylene chloride, contained 14 wt% DFP and 3 wt% CFP. However, when hexane was used as a solvent, accelerated solvent extraction of the corn bran or fiber did not extract any DFP or CFP. Extraction of wheat bran or psyllium hulls with hot methylene chloride did not yield any detectable DFP or CFP. Because it has been suggested that polyamine conjugates such as DFP and CFP may function as natural pesticides, a rapid method was developed to purify them so that their biological activity could be evaluated.

Fos rhythms in the hypothalamus of Rattus and Arvicanthis that exhibit nocturnal and diurnal patterns of rhythmicity.

This study compared patterns of Fos expression within the suprachiasmatic nucleus (SCN), the region immediately dorsal to the SCN (the lower subparaventricular zone, LSPV), and the supraoptic nucleus (SON) of grass rats (Arvicanthis niloticus) and lab rats (Rattus norvegicus). Among grass rats we also compared individuals exhibiting nocturnal and diurnal patterns of wheel running. In the SCN of both groups of grass rats, as well as laboratory rats, Fos was elevated during the light compared to the dark portions of the day, and was expressed in 7-12% of cells containing vasoactive intestinal polypeptide (VIP). Fos was higher in the LSPV during the night compared to the day in both forms of grass rats but not in laboratory rats. In the SON, Fos rose from day to night in the diurnal grass rats and in laboratory rats, but not in nocturnal grass rats. These patterns are consistent with the hypothesis that VIP cells in the SCN function similarly in nocturnal and diurnal rodents, but that the SON and the region dorsal to the SCN are associated with intra and interspecific differences in rhythmicity, respectively.

Water-induced pruritus in haematologically controlled polycythaemia vera: response to phototherapy.

BACKGROUND: Water-induced pruritus is characterized by the development of intense and widespread itching after contact with water at any temperature and without observable skin lesions. Around 40-52% of patients with polycythaemia vera (PV) have water-induced pruritus, and more than 20% of the patients continue with symptoms despite an adequate control of the underlying disease. The aetiology is unknown and treatment is often unsuccessful. We report a patient with a haematologically controlled polycythaemia vera and water-induced pruritus that responded to phototherapy. METHODS: An 83-year-old woman with haematologically controlled PV referred with intense water-induced pruritus without cutaneous lesions. Topical emollients and oral antihistamines were unsatisfactory and so phototherapy treatment (90% UVA/10% UVB) three times a week was commenced. RESULTS: Improvement was visible after 1 month and at the end of 3 months the pruritus had disappeared and treatment was stopped. CONCLUSION: It is considered that the successful treatment in this patient is due to the UVB radiation.